Diagnostic Value of MicroRNAs as Biomarkers for Sepsis-associated Acute Kidney Injury: A Systematic Review and Meta-Analysis
Research Journal of Critical Care Nephrology · 19.10.2026 · 2 (04) · 255-271
DOI: 10.66224/rjccn.2.04.77 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Research Journal of Critical Care Nephrology, online erschienen am 19.10.2026. Verfasst von Farid Javandoust Gharehbagh und 3 weiteren Autor:innen. Die Arbeit nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Introduction
Sepsis-associated acute kidney injury (SA-AKI) is a common and serious complication in critically ill patients, associated with high morbidity and mortality. Early diagnosis remains challenging due to the limitations of traditional biomarkers such as serum creatinine and urine output. MicroRNAs (miRNAs) and circular RNAs (circRNAs) have emerged as promising noninvasive biomarkers for early SA-AKI detection. To systematically evaluate the diagnostic accuracy of individual non-coding RNA biomarkers for predicting SA-AKI in sepsis patients.
Methods
We systematically searched PubMed from inception to August 2026 and manually screened reference lists of relevant systematic reviews. Studies were included if they evaluated noncoding RNAs for SA-AKI diagnosis in sepsis patients, compared sepsis patients with AKI to sepsis patients without AKI.
Results
Fourteen studies comprising 1,840 patients (908 with SA-AKI and 932 controls) were included. The pooled sensitivity was 83.5% and pooled specificity was 81.5%. The pooled DOR was 22.29, and the area under the HSROC curve was 0.885, indicating excellent diagnostic accuracy. The most promising individual biomarkers identified were miR-210 (AUC = 0.913), miR-155 (AUC = 0.910), miR-132-3p (AUC = 0.910), and miR-7695p (AUC = 0.928). Heterogeneity was low to moderate (I²: 30.4 to 35.9% for sensitivity, 0.8 to 0.9% for specificity).
Conclusions
Individual non-coding RNA biomarkers demonstrate good to excellent diagnostic accuracy for SA-AKI, with performance comparable to or exceeding that of established protein biomarkers. Their biological plausibility, stability in body fluids, and potential for early detection make them attractive candidates for clinical translation.
Zitieren
APA
Gharehbagh, F. J., Lotfollahi, L., Gerami, D., & Darazam, I. A. (2026). Diagnostic Value of MicroRNAs as Biomarkers for Sepsis-associated Acute Kidney Injury: A Systematic Review and Meta-Analysis. Research Journal of Critical Care Nephrology, 2(04), 255-271. https://doi.org/10.66224/rjccn.2.04.77
Vancouver
Gharehbagh FJ, Lotfollahi L, Gerami D, Darazam IA. Diagnostic Value of MicroRNAs as Biomarkers for Sepsis-associated Acute Kidney Injury: A Systematic Review and Meta-Analysis. Research Journal of Critical Care Nephrology. 2026;2(04):255-271. doi:10.66224/rjccn.2.04.77
BibTeX
@article{Gharehbagh2026,
author = {Gharehbagh, Farid Javandoust and Lotfollahi, Legha and Gerami, Darya and Darazam, Ilad Alavi},
title = {Diagnostic Value of MicroRNAs as Biomarkers for Sepsis-associated Acute Kidney Injury: A Systematic Review and Meta-Analysis},
journal = {Research Journal of Critical Care Nephrology},
year = {2026},
volume = {2},
number = {04},
pages = {255--271},
doi = {10.66224/rjccn.2.04.77}
}
EUVIMED